Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference May 27, 2020 08:45AM
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock May 22, 2020 04:01PM
Volitionrx Limited (VNRX) Prices 4.37M Share Common Stock Offering at $2.75/sh May 20, 2020 08:47AM
VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock May 20, 2020 08:45AM
Maxim Group Reiterates Buy Rating on VolitionRX (VNRX) on Fosun Long March MOU Mar 28, 2019 12:09PM


May 16, 2018 07:40AM UPDATE: Maxim Group Starts VolitionRX (VNRX) at Buy